Arca
Skip to content
Tools
Tools

Attention deficit disorder with hyperactivity

Drug research and approvals for attention deficit disorder with hyperactivity: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 163 studies of attention deficit disorder with hyperactivity are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 3 authorised medicines for it.

  • Recruiting worldwide: 163
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 3

Recruiting now

Newest posted first, of 163 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 23

Phase 3 12

Phase 2 12 of 50

Phase 1 or earlier 10

How its trials ended

1,272 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 304 whose ending is known, 65% met their primary endpoint, 9% missed it and 26% stopped early.

  • Completed, result not reported62449%
  • Met its primary endpoint19916%
  • Status unknown17614%
  • Ongoing16813%
  • Stopped: other or unclear484%
  • Missed its primary endpoint262%
  • Stopped: enrollment or feasibility161%
  • Stopped: lack of efficacy6<1%
  • Stopped: sponsor or business decision6<1%
  • Stopped: funding3<1%

Medicines authorised in the EU

Newest first
Feb 28, 2025TuzulbyMethylphenidate hydrochlorideNeuraxpharm Pharmaceuticals S.L.EMA ↗
Feb 26, 2025PaxneuryGuanfacine · genericNeuraxpharm Pharmaceuticals S.L.EMA ↗
Sep 17, 2015IntunivGuanfacineTakeda Pharmaceuticals International AG IrelandEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.